Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced that UnitedHealthcare's Medicare Advantage policy has removed CPT 31242 posterior nasal nerve ablation using ...

Q3 2025 Earnings Call Transcript October 29, 2025 AtriCure, Inc. beats earnings expectations. Reported EPS is $-0.01, ...

The new rates reflect a 12% to 15.8% rise over current copays for medications purchased at retail pharmacies and through the ...

A young woman from Gloucester who has been mainly bed-bound and fed through a tube for two years is desperate to be able to ...

Dr. Michael Wolfe shares some of the most common ENT procedures offered to patients. Sponsored by Proliance Surgeons Puget ...

Market Implications: This study update could positively influence AtriCure’s stock performance by demonstrating the potential of its cryoablation device in a new application area. As the company ...

Cancer pain is multifactorial, it may result from the tumor compressing nerves or bones, from treatments such as surgery, ...

Nalu’s PNS system complements Boston’s existing neuromodulation portfolio, which includes its WaveWriter Alpha SCS system for chronic spinal pain.

Over the past few days, medtech's biggest names gathered in San Francisco for the Transcatheter Cardiovascular Therapies (TCT ...

( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced ...

One of the biggest myths about endometriosis is that it magically disappears when menopause begins. But there’s no real ...